Skip to content

A multicenter clinical study to develop the norm and test the reliability and validity of a precision cognition assessment system

A multicenter clinical study to develop the norm and test the reliability and validity of a digital cognitive assessment system in cognitive normal population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054677
Enrollment
Unknown
Registered
2021-12-23
Start date
2021-09-03
Completion date
Unknown
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive disorders

Interventions

Case series:None

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Voluntarily sign the informed consent; 2. The patient aged >=18 years, primary school education level or above, and Chinese is the mother tongue; 3. Normal cognitive function: no complaints and medical history related to cognitive decline (referring to no clear or stable cognitive decline), and MMSE >= 26 points, and normal activities of daily living (Somatic Self-care Ability Scale and Instrumental Activities of Daily Living Scale total score <= 14 points); 4. Have the vision and hearing required to complete the cognitive test.

Exclusion criteria

Exclusion criteria: 1. Suffering from central nervous system diseases: history of stroke, Parkinson's disease or Parkinson's syndrome, traumatic brain dementia, intracranial space-occupying lesions (such as subdural hematoma, brain tumor), infection (such as encephalitis, syphilis) , AIDS, etc.), autoimmune encephalitis, multiple sclerosis, paraneoplastic syndrome, Creutzfeldt-Jakob disease, leukodystrophy, brain damage caused by other physical and chemical factors, etc.; 2. Important physical diseases (such as severe liver and kidney dysfunction, hepatic encephalopathy, pulmonary encephalopathy, advanced cancer, etc.), endocrine system diseases (such as thyroid disease, parathyroid disease) and metabolic factors such as vitamin deficiency; Patients with a history of alcohol or drug abuse during the year; 3. Psychiatric patients, according to DSM-IV-TR criteria, including schizophrenia or other mental illness, bipolar disorder, major depression or delirium.

Design outcomes

Primary

MeasureTime frame
Cognition;

Countries

China

Contacts

Public ContactZhu Yicheng

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

zhuych910@163.com+86 10 69154059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026